NASDAQ NMS - GLOBAL MARKET · VCYT

-2.07% · -$0.8400 · Vol 2.7M

Market closed · last close 4:00 PM ET · price as of 18:24:26 ET

Veracyte Inc

Biotechnology

$39.73

Card

Relationship Map

Follow $VCYT

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $VCYT by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measured

Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET · VCYT

Methodology

Analyst data unavailable at compute time

VCYT

Veracyte Inc

Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET

58/100

Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

58/ 100

Veridion Score

Middle range · MEDIUM confidence · 5 of 6 factors measured

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: MEDIUM · 5 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET

Share on X →

Veridion Score History · 90D

AI Analysis

Sovereign

Why is VCYT moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move VCYT next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Congress

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Mar 3
CongressChecking access
Gilbert Ray Cisneros, Jr. purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Nov 12
CongressChecking access
Gilbert Ray Cisneros, Jr. sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jun 16
CongressChecking access
Gilbert Cisneros purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Oct 16
CongressChecking access
Josh Gottheimer purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Sep 15
CongressChecking access
Josh Gottheimer sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Apr 10
CongressChecking access
Daniel Goldman sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Dec 23
CongressChecking access
Gilbert Cisneros sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Dec 10
CongressChecking access
Gilbert Cisneros sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access

About Veracyte Inc

SERVICES-MEDICAL LABORATORIES

Listed since

2013

Employees

755

Country

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$40.41

Day high

$41.05

Day low

$39.55

Previous close

$40.57

52W high